A glycoconjugate antigen based on the recognition motif of a broadly neutralizing human immunodeficiency virus antibody, 2G12, is immunogenic but elicits antibodies unable to bind to the self glycans of gp120.
The glycan shield of human immunodeficiency virus type 1 (HIV-1) gp120 contributes to viral evasion from humoral immune responses. However, the shield is recognized by the HIV-1 broadly neutralizing antibody (Ab), 2G12, at a relatively conserved cluster of oligomannose glycans. The discovery of 2G12...
Asıl Yazarlar: | Astronomo, R, Lee, H, Scanlan, C, Pantophlet, R, Huang, C, Wilson, I, Blixt, O, Dwek, R, Wong, C, Burton, DR |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
2008
|
Benzer Materyaller
-
The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.
Yazar:: Scanlan, C, ve diğerleri
Baskı/Yayın Bilgisi: (2002) -
A novel form of carbohydrate recognition. The broadly neutralizing anti-HIV-1 antibody 2G12 recognizes a cluster of a1-2 mannose residues on the outer face of GP120
Yazar:: Rudd, P, ve diğerleri
Baskı/Yayın Bilgisi: (2002) -
Engineered gp120 immunogens that elicit VRC01-like antibodies by vaccination
Yazar:: Mata-Fink, Jordi, ve diğerleri
Baskı/Yayın Bilgisi: (2013) -
A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodies
Yazar:: Evan M. Cale, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01) -
Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120.
Yazar:: Moore, J, ve diğerleri
Baskı/Yayın Bilgisi: (1995)